Clinical trials
Tuberculosis trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 14 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asan Medical Center | 7 |
| Seoul National University Hospital | 7 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Yonsei University | 4 |
| Hanyang University | 3 |
| Armed Forces Capital Hospital, Republic of Korea | 2 |
| Green Cross Corporation | 2 |
| Pusan National University Hospital | 2 |
| Quratis Inc. | 2 |
| Inje University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 43 |
| Latent Tuberculosis | 7 |
| Tuberculosis, Pulmonary | 6 |
| Tuberculosis, Multidrug-Resistant | 5 |
| Drug-Related Side Effects and Adverse Reactions | 2 |
| Extensively Drug-Resistant Tuberculosis | 2 |
| Arthritis, Rheumatoid | 1 |
| Chemical and Drug Induced Liver Injury | 1 |
| Disease | 1 |
| Hypersensitivity | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.